Legislation · Minnesota · 2025-2026 Regular Session
HF 4852: Formulary Committee members with a potential conflict of interest permitted to participate in committee communications and discussions, commissioner of human services required to develop a public comment process for recommendations, and committee required to seek expertise from the Minnesota Rare Disease Advisory Council.
Latest recorded action
No action recorded yet.
Apr 7, 2026
This is the latest action supplied by the source, not the full legislative history.
Read the official text and history ↗Track bills like this one
Mandate alerts you when a bill that matters to your organization moves, and explains what it means.
Bill data from LegiScan, licensed under CC BY 4.0. Formatting adjusted by Mandate.